Literature DB >> 30046574

Bridging to liver transplantation patients with a hepatocellular carcinoma within Milan criteria: how worth is it?

Angelo Sangiovanni1, Massimo Colombo2.   

Abstract

Entities:  

Year:  2018        PMID： 30046574      PMCID： PMC6036065          DOI： 10.21037/hbsn.2018.03.12

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  14 in total

1.  Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.

Authors:  Gunda Millonig; Ivo W Graziadei; Martin C Freund; Werner Jaschke; Sylvia Stadlmann; Ruth Ladurner; Raimund Margreiter; Wolfgang Vogel
Journal:  Liver Transpl       Date:  2007-02       Impact factor: 5.799

2.  Clinical significance of the best response during repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma.

Authors:  Jonggi Choi; Ju Hyun Shim; Yong Moon Shin; Kang Mo Kim; Young-Suk Lim; Han Chu Lee
Journal:  J Hepatol       Date:  2014-01-29       Impact factor: 25.083

3.  Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.

Authors:  Vatche G Agopian; Michael P Harlander-Locke; Richard M Ruiz; Goran B Klintmalm; Srinath Senguttuvan; Sander S Florman; Brandy Haydel; Maarouf Hoteit; Matthew H Levine; David D Lee; C Burcin Taner; Elizabeth C Verna; Karim J Halazun; Rita Abdelmessih; Amit D Tevar; Abhinav Humar; Federico Aucejo; William C Chapman; Neeta Vachharajani; Mindie H Nguyen; Marc L Melcher; Trevor L Nydam; Constance Mobley; R Mark Ghobrial; Beth Amundsen; James F Markmann; Alan N Langnas; Carol A Carney; Jennifer Berumen; Alan W Hemming; Debra L Sudan; Johnny C Hong; Joohyun Kim; Michael A Zimmerman; Abbas Rana; Michael L Kueht; Christopher M Jones; Thomas M Fishbein; Ronald W Busuttil
Journal:  Ann Surg       Date:  2017-09       Impact factor: 12.969

4.  The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.

Authors:  Shaheed Merani; Pietro Majno; Norman M Kneteman; Thierry Berney; Philippe Morel; Gilles Mentha; Christian Toso
Journal:  J Hepatol       Date:  2011-02-18       Impact factor: 25.083

5.  Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?

Authors:  Marc-Antoine Allard; Mylène Sebagh; Aldrick Ruiz; Catherine Guettier; Bernard Paule; Eric Vibert; Antonio Sa Cunha; Daniel Cherqui; Didier Samuel; Henri Bismuth; Denis Castaing; René Adam
Journal:  J Hepatol       Date:  2015-01-31       Impact factor: 25.083

6.  Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.

Authors:  Vatche G Agopian; Maud M Morshedi; Justin McWilliams; Michael P Harlander-Locke; Daniela Markovic; Ali Zarrinpar; Fady M Kaldas; Douglas G Farmer; Hasan Yersiz; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2015-09       Impact factor: 12.969

7.  Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation.

Authors:  Quirino Lai; Alfonso W Avolio; Ivo Graziadei; Gerd Otto; Massimo Rossi; Giuseppe Tisone; Pierre Goffette; Wolfgang Vogel; Michael B Pitton; Jan Lerut
Journal:  Liver Transpl       Date:  2013-10       Impact factor: 5.799

Review 8.  Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis.

Authors:  C Boutros; P Somasundar; S Garrean; A Saied; N J Espat
Journal:  Surg Oncol       Date:  2009-03-06       Impact factor: 3.279

9.  Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.

Authors:  Vincenzo Mazzaferro
Journal:  Hepatology       Date:  2016-02-26       Impact factor: 17.425

10.  Response to transarterial chemoembolization may serve as selection criteria for hepatocellular carcinoma liver transplantation.

Authors:  Jianyong Lei; Jinjing Zhong; Yefang Luo; Lunan Yan; Jinqiang Zhu; Wentao Wang; Bo Li; Tianfu Wen; Jiaying Yang
Journal:  Oncotarget       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.